Morpholino

MO2-itga7

ID
ZDB-MRPHLNO-080930-2
Name
MO2-itga7
Previous Names
  • integrin a7-splice MO (1)
Target
Sequence
5' - CTCAGATCAGTGCAGACTCACCAGC - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genome Build: GRCz11Chromosome: 11
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-itga7
No data available
Phenotype
Phenotype resulting from MO2-itga7
Phenotype Fish Figures
locomotion involved in locomotory behavior decreased rate, abnormal WT + MO2-itga7 Fig. 8 with image from Goody et al., 2012
myotome muscle cell detached from myotome muscle tendon junction, abnormal WT + MO2-itga7 Fig. 3 with image,  Fig. 7 with image from Goody et al., 2012
skeletal muscle cell actin cytoskeleton retracted, abnormal WT + MO2-itga7 Fig. 3 with image from Postel et al., 2008
whole organism paralysed, abnormal WT + MO2-itga7 Fig. 3 with image from Postel et al., 2008
1 - 4 of 4
Phenotype of all Fish created by or utilizing MO2-itga7
Phenotype Fish Conditions Figures
whole organism paralysed, abnormal WT + MO2-itga7 standard conditions Fig. 3 with image from Postel et al., 2008
locomotion involved in locomotory behavior decreased rate, abnormal WT + MO2-itga7 standard conditions Fig. 8 with image from Goody et al., 2012
skeletal muscle cell actin cytoskeleton retracted, abnormal WT + MO2-itga7 standard conditions Fig. 3 with image from Postel et al., 2008
myotome muscle cell detached from myotome muscle tendon junction, abnormal WT + MO2-itga7 standard conditions Fig. 3 with image,  Fig. 7 with image from Goody et al., 2012
locomotion involved in locomotory behavior decreased rate, abnormal WT + MO2-itga7 chemical treatment: NAD(+) Fig. 8 with image from Goody et al., 2012
1 - 5 of 17 Show all
Citations
TSV
1 - 2 of 2
Show
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.